AYTU
Aytu BioPharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 5
Bearish signal 0
Stock Price Surged Significantly
Consensus Rating "Strong Buy"
High Gross Profit Margin
Significant Net Income Growth
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About AYTU
Aytu Biopharma, Inc.
A pharmaceutical company that develops novel products in the field of urology in the United States
7900 East Union Avenue, Suite 920, Denver, Colorado 80237
--
Aytu BioPharma, Inc., was originally established in Colorado, USA on August 9, 2002. The company is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life of patients. The Company operates through two business segments: (i) the Rx segment, which includes prescription drug products; and (ii) the Consumer Healthcare segment, which includes a variety of consumer healthcare products.
Earnings Call
Q4/2025
Estimate EPS-0.06
Actual EPS-2.93
Estimate Revenue17.92M
Actual Revenue15.14M
Q4 2025: Contradictions Emerge in ADHD Franchise Growth, Breakeven Revenue Projections, and EXXUA Launch Timing
Sep 23,2025 09:56
Earnings Decrypt
Earnings Decrypt
Q1/2026
Estimate EPS-0.19
Actual EPS-0.08
Estimate Revenue12.60M
Actual Revenue13.89M
Aytu BioPharma's 2026Q1 Earnings Call: Contradictions Emerge on Payer Strategy, EXXUA Launch, and Sales Growth Expectations
Nov 16,2025 08:45
Earnings Decrypt
Earnings Decrypt
Q3/2025
Estimate EPS--
Actual EPS0.2
Estimate Revenue13.74M
Actual Revenue18.45M
Aytu BioPharma's Q3 2025: Contradictions in ADHD and Pediatric Growth Strategies Unveiled
May 20,2025 04:17
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
AYTU has released its 2026 Q1 earnings. EPS was reported at -0.08, versus the expected -0.19, beating expectations. The chart below visualizes how AYTU has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
AYTU has released its 2026 Q1 earnings report, with revenue of 13.89M, reflecting a YoY change of -16.21%, and net profit of 1.97M, showing a YoY change of 33.31%. The Sankey diagram below clearly presents AYTU's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
